Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0KSX stock hub

LON/0KSX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0KSXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0KSX

In the news

Latest news · LON/0KSX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.8

P25 12.9P50 16.9P75 23.5

Trailing P/E19.7

P25 15.9P50 22.9P75 35.8

ROE14.5

P25 -54.2P50 2.1P75 13.7

ROIC9.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0KSX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	51,500
Employees Change	1,000%
Employees Change Percent	1.79
Enterprise value	$19.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US74834L1008
Last refreshed	2026-05-10
Market cap	$15.2B
Price	$189
Price currency	USD
Rev Per Employee	165,842.44x
Sector	Healthcare
Sic	8071
Symbol	lon/0KSX
Website	https://www.questdiagnostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.07%
EV Earnings	25.78x
EV/EBIT	16.18x
EV/EBITDA	9.9x
EV/FCF	19.83x
EV/Sales	2.41x
FCF yield	6.6%
Forward P/E	16.79x
P/B ratio	2.6x
P/E ratio	19.71x
P/S ratio	1.78x
PE Ratio10 Y	16.76x
PE Ratio3 Y	19.75x
PE Ratio5 Y	16.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.62%
EBITDA Margin	19.74%
FCF margin	11.76%
Gross margin	33.28%
Gross Profit	$2.8B
Gross Profit Growth	11.76%
Gross Profit Growth Q	8.63%
Gross Profit Growth3 Y	4.61%
Gross Profit Growth5 Y	-2.51%
Net Income	$772.5M
Net Income Growth	14.16%
Net Income Growth Q	14.55%
Net Income Growth Quarters	7%
Net Income Growth Years	2%
Net Income Growth3 Y	8.94%
Net Income Growth5 Y	-10.68%
Pretax Margin	12.45%
Profit Margin	9.08%
Profit Per Employee	$14,999
Profitable Years	14
ROA	6.35
Roa5y	7.22
ROCE	11.38
ROE	14.54
Roe5y	18.06
ROIC	9.28
Roic5y	11.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.54%
Cagr3y	13.79%
Cagr5y	8.75%
Div CAGR3	2.59%
Div CAGR5	6.92%
EPS Growth	14.45
EPS Growth Q	15.46
EPS Growth Quarters	7
EPS Growth Years	2
EPS Growth3 Y	10.02
EPS Growth5 Y	-7.24
FCF Growth	25.57%
FCF Growth Q	-16.75%
FCF Growth3 Y	15.35%
FCF Growth5 Y	-8.5%
OCF Growth	23.83%
OCF Growth Q	-11.47%
OCF Growth10 Y	7.21%
OCF Growth3 Y	11.57%
OCF Growth5 Y	-5.76%
Revenue Growth	11.03x
Revenue Growth Q	9.16x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	5.51x
Revenue Growth5 Y	1.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.69
Assets	$12.6B
Cash	$297.6M
Current Assets	$1.9B
Current Liabilities	$1.6B
Debt	$4.9B
Debt EBITDA	$2.36
Debt Equity	$0.83
Debt FCF	$4.83
Equity	$5.9B
Interest Coverage	6.11
Liabilities	$6.8B
Long Term Assets	$10.7B
Long Term Liabilities	$5.2B
Net Cash	$-4.6B
Net Cash By Market Cap	$-29.92
Net Debt EBITDA	$2.7
Net Debt Equity	$0.78
Net Debt FCF	$4.54
Tangible Book Value	$-2.6B
Tangible Book Value Per Share	$-23.68
WACC	6.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.18
Inventory Turnover	36.35
Net Working Capital	$509.7M
Quick ratio	0.91
Working Capital	$294.6M
Working Capital Turnover	$16.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.44%
Dividend Growth	1.05%
Dividend Growth Years	8%
Dividend per share	$2.43
Dividend Years	9
Dividend Yield	1.28%
Ex Div Date	2026-04-06
Last Dividend	$0.65
Payout Frequency	Quarterly
Payout Ratio	34.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.53%
200-day SMA	186.7
3Y total return	47.33%
50-day SMA	197.5
50-day SMA vs 200-day SMA	50over200
5Y total return	52.1%
All Time High	214.4
All Time High Change	-11.88%
All Time High Date	2026-02-27
All Time Low	74.03
All Time Low Change	155.26%
All Time Low Date	2020-04-03
ATR	6.13
Beta	0.6
Ch YTD	8.22
High	192.9
High52	214.4
High52 Date	2026-02-27
High52ch	-11.88%
Low	188.1
Low52	165.4
Low52 Date	2025-07-15
Low52ch	14.29%
Ma50ch	-4.31%
Price vs 200-day SMA	1.22%
RSI	36.01
RSI Monthly	55.58
RSI Weekly	47.26
Sharpe ratio	0.24x
Sortino ratio	0.63
Total Return	1.73%
Tr YTD	9.2
Tr1m	-4.11%
Tr1w	-2.06%
Tr3m	-0.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.2B
Operating Income Growth	12.87
Operating Income Growth Q	11.99
Operating Income Growth3 Y	6.95
Operating Income Growth5 Y	-8.62
Operating margin	14.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	110,080,732%
Net Borrowing	-159,906,052
Shares Insiders	0.42%
Shares Institutions	97.79%
Shares Qo Q	0%
Shares Yo Y	-0.44%
Short Ratio	3.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$939.1M
Average Volume	435.1x
Bv Per Share	50.26
CAPEX	$-396.8M
Ch1m	-4.11
Ch1w	-2.06
Ch1y	6.6
Ch3m	-1.16
Ch3y	38.78
Ch5y	37.94
Ch6m	5.77
Change	-0.36%
Change From Open	-0.87
Close	189.7
Days Gap	0.51
Depreciation Amortization	423,237,578
Dollar Volume	5,669.1
Earnings Date	2026-04-21
EBIT	$1.2B
EBITDA	$1.7B
EPS	$6.85
F Score	7
FCF	$1B
FCF EV Yield	5.04x
Financing CF	-741,401,595
Fiscal Year End	December
Founded	1,967
Goodwill	6,689,647,680
Graham Number	125.33162
Graham Upside	-33.68
Income Tax	$249.2M
Investing CF	-505,879,740
Is Primary Listing	0
Last Earnings Date	2026-04-21
Last Report Date	2026-03-31
Lynch Fair Value	$47.94
Lynch Upside	-74.63
Ma150	189.2
Ma150ch	-0.13%
Ma20	193.9
Ma20ch	-2.52%
Net CF	155,247,525
Open	190.6
P FCF Ratio	15.16
P OCF Ratio	10.87
Payment Date	2026-04-20
Position In Range	18.2
Ppne	2,112,520,320
Price Date	2026-05-08
Price EBITDA	$9.03
Relative Volume	0.07x
Revenue	8,540,885,790x
SBC By Revenue	0.76x
Share Based Comp	65,128,230
Tax By Revenue	2.92x
Tax Rate	23.43%
Tr6m	6.72%
Volume	30
Z Score	3.24

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0KSX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.3%

$2.43 annual per share

Payout ratio

+34.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.9%

8 consecutive years of growth

Total shareholder yield

+1.7%

Next ex-dividend date: 2026-04-06

Performance

LON/0KSX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0KSX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+97.8%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0KSX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.0

Neutral momentum band

Price vs 200-day MA

+1.2%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0KSX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0KSX stock rating?

lon/0KSX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0KSX analysis?

The full report lives at /stocks/lon/0KSX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0KSX?

The latest report frames lon/0KSX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0KSX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.